Idorsia Stock Fundamentals
| IDIA Stock | CHF 0.76 0.08 9.52% |
Idorsia fundamentals help investors to digest information that contributes to Idorsia's financial success or failures. It also enables traders to predict the movement of Idorsia Stock. The fundamental analysis module provides a way to measure Idorsia's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Idorsia stock.
Idorsia |
Idorsia Company Operating Margin Analysis
Idorsia's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Idorsia Operating Margin | (8.25) % |
Most of Idorsia's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Idorsia is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Idorsia has an Operating Margin of -8.2518%. This is 76.48% lower than that of the Healthcare sector and 92.64% lower than that of the Biotechnology industry. The operating margin for all Switzerland stocks is 49.76% higher than that of the company.
Idorsia Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Idorsia's current stock value. Our valuation model uses many indicators to compare Idorsia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Idorsia competition to find correlations between indicators driving Idorsia's intrinsic value. More Info.Idorsia is rated second overall in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Idorsia's earnings, one of the primary drivers of an investment's value.Idorsia Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Idorsia's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Idorsia could also be used in its relative valuation, which is a method of valuing Idorsia by comparing valuation metrics of similar companies.Idorsia is currently under evaluation in operating margin category among its peers.
Idorsia Fundamentals
| Return On Equity | -64.61 | |||
| Return On Asset | -0.42 | |||
| Operating Margin | (8.25) % | |||
| Current Valuation | 2.88 B | |||
| Shares Outstanding | 187.56 M | |||
| Shares Owned By Insiders | 36.02 % | |||
| Shares Owned By Institutions | 23.03 % | |||
| Price To Book | 27.65 X | |||
| Price To Sales | 48.84 X | |||
| Revenue | 97.1 M | |||
| Gross Profit | (292.5 M) | |||
| EBITDA | (783.09 M) | |||
| Net Income | (827.9 M) | |||
| Cash And Equivalents | 811.85 M | |||
| Cash Per Share | 6.19 X | |||
| Total Debt | 1.13 B | |||
| Debt To Equity | 112.20 % | |||
| Current Ratio | 7.57 X | |||
| Book Value Per Share | (3.72) X | |||
| Cash Flow From Operations | (859.11 M) | |||
| Earnings Per Share | (4.26) X | |||
| Target Price | 16.53 | |||
| Number Of Employees | 11 | |||
| Beta | 0.57 | |||
| Market Capitalization | 2.31 B | |||
| Total Asset | 904.18 M | |||
| Z Score | 1.2 | |||
| Net Asset | 904.18 M |
About Idorsia Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Idorsia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Idorsia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Idorsia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland. Idorsia Ltd is traded on Switzerland Exchange in Switzerland.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Idorsia Stock Analysis
When running Idorsia's price analysis, check to measure Idorsia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idorsia is operating at the current time. Most of Idorsia's value examination focuses on studying past and present price action to predict the probability of Idorsia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idorsia's price. Additionally, you may evaluate how the addition of Idorsia to your portfolios can decrease your overall portfolio volatility.